Eric Buch MBBCh, MSc(Med), DTM&H, DOH, FFCH(CM)(SA) is Professor of Health Policy and Management at the University of Pretoria (UP) and the lead of its Albertina Sisulu Executive Leadership Programme in Health. He is the Chairperson of the Board of the National Health Laboratory Service.
Eric was formerly Dean of the Faculty of Health Sciences at UP; Health Advisor for the New Partnership for Africa’s Development (NEPAD); Deputy Director General for Health Care of Gauteng Province; Executive Director for Health, Housing and Urbanisation of Johannesburg and a Director of the Centre for Health Policy at the University of the Witwatersrand. In 2015 Eric was awarded the Public Health Association of South Africa’s “Phila” Lifetime Achievement Award.
Dr. Chikwe Ihekweazu, MBBCH, FCPaeds (SA), DSc (honoris causa), and National Research Foundation (NRF) Dr. Chikwe Ihekweazu is the Director General of the Nigeria Centre for Disease Control (NCDC) and was until January 2018, the Acting Director of the West Africa Regional Centre for Disease Control. Dr Ihekweazu trained as an infectious disease epidemiologist and has over 20 years’ experience working in senior public health and leadership positions in several National Public Health Institutes, including the South African National Institute for Communicable Diseases (NICD), the UK’s Health Protection Agency, and Germany’s Robert Koch Institute (RKI). Dr Ihekweazu has led several short-term engagements for WHO, mainly in response to major infectious disease outbreaks around the world.
Professor Colleen Wright, Prof Colleen Wright is a pathologist with an interest in both Paediatric Pathology and Cytopathology, particularly the use of FNAB as a diagnostic modality in resource limited countries which has led to research into the diagnosis of paediatric tuberculosis using FNAB, the topic of her doctoral dissertation as well as the promotion of FNAB in both neoplastic and infectious diseases in countries with limited financial and medical personnel resources. For this she received the South African Medical Association Special Medical Service Award in 2010. She trains medical and nursing staff at under and post graduate level in FNA technique and initiated the first distance mediated Master’s degree in Cytopathology through Stellenbosch University, enabling specialist training in cytopathology accessible to students throughout Africa. Prof Wright is and has been a member of many national and international professional organizations and committees, including the IAC, the International Board of Cytopathology, Paediatric Pathology Society, and IAP (SA Division), She has in excess of 100 peer reviewed publications and book chapters and has supervised and co supervised more than 40 masters and doctoral dissertations.
Mr. Tyron Grant, Mr. Tyron Grant is a South African Patent attorney specializing in domestic and international patent matters, particularly in the field of Biotechnology and Life Sciences, including the preparation and prosecution of patent applications. He also assists with litigation matters related to biotechnological inventions and providing advice in respect of the Genetically Modified Organisms Act (“the GMO Act”), Plant Breeders’ Rights Act (“The PBR Act”) and National Environmental Management: Biodiversity Act (NEMBA). He received his masters’ degree in Genetics from the University of Pretoria in 2004 and is a member of the Biotech department at Spoor & Fisher where he has worked since 2005. He received his LLB from UNISA in 2008 and was admitted as an attorney of the Law Society of the Northern Provinces in 2009. He has been a registered South African Patent Attorney since 2009. He became a partner of the firm and a Fellow of the South African Institute for Intellectual Property Law in 2013.
Dr Jonathan Louw, MB.ChB, MBA, CEO of the South African National Blood Service (SANBS), which caters to the value chain of blood donation, testing and logistics through transfusion to patients across South Africa. Previously Co-CEO for the Global Healthcare Fund in Dubai, raising and deploying $1bn in Hospitals and Diagnostics in global growth markets. Prior he was the CEO and Managing Director at Adcock Ingram Holdings Limited. Dr Louw led the IPO of Adcock Ingram when it separated from the JSE-Listed TigerBrands and during his tenure the business adopted an aggressive growth strategy, re-investing manufacturing and R&D to achieve FDA and PIC/s accreditation in both. He then joined TigerBrands as the New Business Development Director. Dr Louw first joined the pharmaceutical industry through AstraZeneca. He practised as an Anesthetist at St. Mary's Hospital in London, having trained as an undergraduate at the University of Cape Town faculty of Medicine. He has also served as the President of the Pharmaceutical Industry Association of South Africa, representing the interest of local and multi-national pharmaceutical companies, and is a Board member of Generation Ubuntu (NYC) looking after Orphans afflicted with HIV/AIDS in South Africa.
PathRed EvaluationsClick to Evaluate
Already RegisteredClick to login
View Invited Speakers
PathReD Scientific Programme